Search Results 121-130 of 16641 for immunosuppressant drugs

  1. Mayo Clinic urges cancer patients to seek third dose of mRNA COVID-19 vaccine

    Patients with an additional immunosuppressive condition, such as HIV or patients being treated with immunosuppressive agents unrelated to their cancer therapy.

  2. Heart Transplant Research Program - Transplant Research Center - Mayo Clinic Research

    The Heart Transplant Research Program at Mayo Clinic studies immunosuppression, managing immunosuppressive medications and identifying novel biomarkers.

  3. Drugs and Supplements that Start with I - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “I” to learn about drug side effects, proper use and ...

  4. Consumer Health: What do you know about these 3 rare rheumatic diseases?

    There is no cure for Churg-Strauss syndrome. Treatment with steroids and other powerful immunosuppressant drugs can manage symptoms. Takayasu's arteritis.

  5. MS or not MS? Mayo Clinic Neuroimmunology Lab answers the question

    Park, M.D., Director of the Center for Multiple Sclerosis and Autoimmune Neurology. “We generally use immunosuppressant drugs to prevent attacks in both AQP4 ...

  6. Skin cancer - Symptoms and causes - Mayo Clinic

    This includes people living with HIV/AIDS and those taking immunosuppressant drugs after an organ transplant. Exposure to radiation. People who received ...

  7. Monoclonal antibody treatment can help high-risk patients with COVID-19 - Mayo Clinic News Network

    ... immunosuppressive drugs," says Dr. Razonable. Dr. Razonable explains that a ... drug because they thought that they don't need it because they feel ...

  8. Everolimus (oral route) - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  9. Liver transplant - Mayo Clinic

    Drugs called immunosuppressants help keep your immune system from attacking your new liver. Other drugs help reduce the risk of other complications after ...

  10. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...